2015-2019 U.S. Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies-Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

2015-2019 U.S. Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies-Infectious Disease

Category : Diagnostic and Biotech
Published On : September  2015
Pages : 1157



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
This report presents a comprehensive analysis of the US molecular diagnostics market, including: 
  • Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts for the following categories:

   -  Infectious Diseases                  -  Genetic Diseases
   -  Cancer                                      -  Paternity Testing/HLA Typing
   -  Forensic Testing 

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.
Contains 1,157 pages and 65 tables
image
Can't read the image ? refresh here.


Enquiry Before Buy
image
Can´t read the image ? refresh here.